Papers

WELCOME TO이화여대 AI-사회약학규제과학 연구실

Publications

Papers

> Publications > Papers

Papers
번호	제목
62	[before 2021] Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study
61	[before 2021] Public preferences for corporate social responsibility activities of the pharmaceutical industry: Empirical evidence from Korea
60	[before 2021] Causality Assessment Guidelines for Adverse Events Following Immunization with a Focus on Guillain–Barré Syndrome
59	[before 2021] Socioeconomic impact of the rotavirus vaccine in Korea: Comparing the epidemiologic and economic characteristics of rotavirus gastroenteritis before and after the introduction of vaccines
58	[before 2021] Signals and trends of Guillain–Barré Syndrome after the introduction of live-attenuated vaccines for influenza in the US and South Korean adverse event reporting systems
57	[before 2021] Incidence of Guillain–Barré Syndrome is not associated with influenza vaccination in the elderly
56	[2021-2022] Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea
55	[before 2021] Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial
54	[before 2021] Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older
53	[2021-2022] Cost-effectiveness analysis of antiviral therapy for untreated minimally active chronic hepatitis B to prevent liver disease progression
52	[2021-2022] Epidemiological features and economic burden of Guillain–Barré Syndrome in South Korea: a nationwide population-based study
51	[2021-2022] Association between depression and antibiotic use: analysis of population-based National Health Insurance claims data
50	[2021-2022] Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
49	[2021-2022] ALK-양성 비소세포성 폐암 환자 대상 Alectinib과 Crizotinib의 무진행 생존기간 효능 비교: 체계적 문헌 고찰 및 메타분석
48	[2021-2022] Cost-Effectiveness of Chronic Hepatitis C screening and treatment
47	[2021-2022] Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level<2,000 IU/mL
46	[2021-2022] Efficacy and Safety of Opicapone for Motor Fluctuations as an Adjuvant to Levodopa Therapy in Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis
45	[2021-2022] Gender Difference in Health-Related Behaviors associated with Metabolic Status-Obesity Phenotypes among Korean Adults
44	[2021-2022] Focus Group Interview of Stakeholders to Derive Checklists for Future Real-world Data and Real-world Evidence Use in Regulatory Decision Making for Drugs
43	[2021-2022] A Micro-Costing Analysis of Flexible Bronchoscopic Intubation in a Korean Tertiary Hospital
42	[2021-2022] Real-world clinical features, health-care utilization, and economic burden in decompensated cirrhosis patients: A national database
41	[2021-2022] Comparison of netarsudil/latanoprost therapy with latanoprost monotherapy for lowering intraocular pressure: a systematic review and meta-analysis
40	[2021-2022] 적절한 폐의약품 처리 방법에 대한 약대생의 인식 및 지식 설문조사
38	[2021-2022] New evidence of oral branched-chain amino acid supplementation on the prognosis of patients with advanced liver disease
37	[2021-2022] Long-term cost-effectiveness of fractional flow reserve-based percutaneous coronary intervention in stable and unstable angina
36	[2026] Optimizing Hepatitis C Micro-elimination in Forensic Psychiatric Settings: Cost-effectiveness of Screening Strategies in Korea
35	[2026] Risk of Neurological Adverse Events Between PD-L1 and PD-1 Inhibitors in South Korean Patients with Lung Cancer: A Target Trial Emulation Framework
34	[2026] Association Between Cancer Stage and Parenting Self-Efficacy in Breast Cancer Survivors: A Survey of a Triple-Negative Breast Cancer Community
33	[2026] Safety of Potassium-Competitive Acid Blockers Compared with Proton Pump Inhibitors in Patients with Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta-analysis
32	[2026] Nationwide Insights on Early Childhood Neurodevelopment During a Global Health Crisis: Evidence from COVID-19 in South Korea
31	[2025] Treatment Patterns and Survival Outcomes in Korean Patients with Metastatic Hormone-Sensitive Prostate Cancer in a Real-World Setting
30	[2025] Analysis of Medication Adherence and Influencing Factors in Patients With Treatment-Resistant Hypertension in South Korea: A Nationwide Retrospective Cohort Study
29	[2026] Economic Evaluation of Empirical and Tailored Helicobacter pylori Eradication Strategies including Second-Line Therapy
28	[2026] Prostate Cancer in Korea: Nationwide Trends in Prevalence and Medication Use During 2011-2021
27	[2026] Risk of Liver and Kidney Adverse Events After Androgen Deprivation Therapy in Prostate Cancer: A Population-Based Retrospective Cohort Study
26	[2026] Renal Outcomes With Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors in CKD
25	[2026] Comparative risk of pneumonia and acute exacerbation between P-CAB and PPI use in patients with COPD and GERD
24	[2026] 유전자치료제의 급여 및 재정 지불 모형에 대한 국제 비교 및 정책적 함의
23	[2026] Economic Burden of Treatment Resistant Depression in Korea: A 28-Day Health-State-Specific Cost Analysis
22	[2025] Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea
21	[2025] Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs
20	[2025] Risk of Alzheimer’s disease and Parkinson’s disease following androgen deprivation therapy in a real world nationwide cohort
19	[2025] A multicenter micro-costing analysis of flexible cystoscopic procedures in Korea
18	[2025] Assessing the Risk of Cognitive Impairment associated with Androgen Receptor Targeting Agent Use in Metastatic Prostate Cancer: A Systematic Review of Real-world Data
17	[2025] COVID-19 infection in patients with end-stage kidney disease undergoing renal replacement therapies in Korea
16	[2025] Clinician guidance in digital therapeutics for panic disorder: Meta-analytic dissection and implications for regulatory framing and scalable deployment
15	[2025] Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree Analysis
14	[2025] Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea
13	[2025] Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs
12	[2025] Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records
11	[2025] Oral Branched-Chain Amino Acids as a Cost-Effective Option for Managing Hepatic Encephalopathy
10	[2025] Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study
9	[2025] Risk of Alzheimer's disease and Parkinson's disease following androgen deprivation therapy in a real world nationwide cohort
8	[2025] Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness
7	[2025] 수원시 거주자의 혈압 및 혈당 인지율의 지역 간 격차와 관련 요인
6	[2023-2024] Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's Disease
5	[2023-2024] Determinants of immune checkpoint inhibitor use and factors linked to neurological adverse events in Korean lung cancer
4	[2023-2024] Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea
3	[2023-2024] Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic
2	[2023-2024] Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea
1	[2023-2024] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study